Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise
Release time:
2020-08-14
Achieve "Jumping" in One Year to Fill in the Blank of Jinhua City
Peak Pharmaceutical Industry Becomes National Intellectual Property Demonstration Enterprise
It is only one year since was identified as a national intellectual property advantage enterprise in 2016 , "Zhejiang Jianfeng Pharmaceutical Co., Ltd." has appeared in the list of national intellectual property demonstration enterprises in the year 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City.
12 September 12 , the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017 . After enterprise declaration, recommendation by provincial and municipal bureaus, examination by national bureaus, and public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as a national intellectual property demonstration enterprise only 15 .
With the continuous development of enterprises in recent years, Pinnacle Pharmaceutical has set up a special working organization to cultivate and enhance intellectual property capabilities in terms of strategic management, creation, operation and protection of intellectual property rights, it has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System", and revised them in time according to policies and the current situation of enterprises to ensure the compliance and effectiveness of system operation. In 2012 and in 2013 , Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province. won the third prize of Jinhua Patent Implementation Award in 2013 ; passed the intellectual property management system certification in 2016 and was identified as a national intellectual property advantage enterprise. At present, Jianfeng Pharmaceutical has 140 domestic and foreign applications and 127 registered authorizations for various inventions, utility models and trademark intellectual property rights, including 1 well-known trademarks in China, 2 well-known trademarks in Zhejiang Province and 5 well-known trademarks in Jinhua City. In terms of intellectual property operation, improvement of innovation efficiency, and promotion of ownership and industrialization of innovation achievements, active attempts are also made.
Under normal circumstances, the construction of a national intellectual property advantage enterprise expires for three years, and only after the assessment reaches the standard can it be upgraded to a demonstration enterprise. However, it only took one year for Jianfeng Pharmaceutical to complete the leap from an "advantage enterprise" to a "demonstration enterprise. This indicates that the level of intellectual property creation, management, application and protection of Jianfeng Pharmaceutical has entered a higher level. It is understood that Jianfeng Pharmaceutical has achieved excellent results in the annual assessment of national intellectual property advantage enterprises, which is an important reason for this "jump. Through the implementation of the national standard of "enterprise intellectual property management standard" and the cultivation of advantageous enterprises and demonstration enterprises, Jianfeng pharmaceutical has realized the advanced development of "improving the foundation of intellectual property management, cultivating intellectual property advantages and forming comprehensive competitive advantages". It can not only protect itself, but also avoid infringing on the rights and interests of other enterprises, It provides strong support for the economic transformation and upgrading of enterprises, improving quality and efficiency. In addition, this time it has been identified as a national intellectual property demonstration enterprise, and Jianfeng Pharmaceutical will also receive a 30 yuan award from Jinhua City.
According to the requirements of the documents of the State Intellectual Property Office, the construction period of the national intellectual property demonstration enterprise in 2017 is from 2017 12 to 2020 11 . During this period, local intellectual property management departments should, in accordance with relevant requirements and combined with actual work, explore the establishment of a distinctive enterprise cultivation policy system, further improve the overall plan for the cultivation of demonstration enterprises and advantageous enterprises in the region, and clarify the phased tasks of cultivation. Increase investment, guarantee special funds, gather expert resources and support measures, and strengthen targeted guidance, service, supervision and inspection of enterprise intellectual property work. As a demonstration enterprise, Jianfeng Pharmaceutical will also further formulate a work plan for the construction of demonstration enterprises, establish and improve work leadership and overall coordination mechanisms, further strengthen the management and implementation of intellectual property strategies, increase guarantees, and ensure that the construction of demonstration enterprises achieves practical results and realizes knowledge The development goal of a strong enterprise with property rights. (Reporter Fu Yiwu)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page